Initial Management of Corona Radiata Stroke (tPA Eligible)
For patients with corona radiata stroke who are eligible for tissue plasminogen activator (tPA), immediate administration of intravenous alteplase (0.9 mg/kg, maximum dose 90 mg) is recommended within 4.5 hours of symptom onset, with earlier treatment associated with better outcomes.
Immediate Assessment and Triage
- Assign high-severity triage category to be seen within 10 minutes of ED arrival 1
- Activate "Code Stroke" protocol to expedite evaluation and treatment 1
- Perform rapid assessment of:
Urgent Diagnostic Evaluation
- Obtain immediate non-contrast CT scan of the brain within 25 minutes of arrival 1
- CT should be interpreted within 45 minutes of arrival 1
- Primary purpose: rule out hemorrhage and identify early signs of infarction
- Essential laboratory tests:
- Complete blood count with platelets
- Electrolytes and renal function
- Coagulation studies
- Blood glucose
- Troponin 2
- 12-lead ECG to identify atrial fibrillation or evidence of structural heart disease 2
tPA Administration Protocol
Eligibility assessment:
- Confirm diagnosis of ischemic stroke with measurable neurologic deficit
- Verify symptom onset is within 4.5 hours
- Review contraindications (see below)
- Ensure blood pressure is <185/110 mmHg 1
tPA dosing and administration:
- Administer 0.9 mg/kg (maximum dose 90 mg)
- Give 10% as initial bolus over 1 minute
- Infuse remaining 90% over 60 minutes 1
Blood pressure management:
- Before tPA: maintain BP <185/110 mmHg
- During and after tPA: maintain BP <180/105 mmHg for at least 24 hours
- Monitor BP every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly for 16 hours 1
- For elevated BP:
- Labetalol 10-20 mg IV over 1-2 minutes (may repeat once), or
- Nicardipine IV 5 mg/hr, titrate up by 2.5 mg/hr every 5-15 minutes (maximum 15 mg/hr) 1
Key Contraindications to tPA
- Head trauma or prior stroke in previous 3 months
- Symptoms suggesting subarachnoid hemorrhage
- Arterial puncture at noncompressible site in previous 7 days
- History of previous intracranial hemorrhage
- Elevated blood pressure (systolic >185 mmHg or diastolic >110 mmHg)
- Evidence of active bleeding
- Acute bleeding diathesis
- Blood glucose <50 mg/dL
- CT showing multilobar infarction (hypodensity >1/3 cerebral hemisphere) 1
Post-tPA Management
- Position patient in semi-recumbent position to prevent aspiration 2
- Avoid antiplatelet or anticoagulant medications for 24 hours after tPA administration 2
- Continue neurological monitoring with serial examinations to detect early deterioration 2
- Monitor for complications:
- Symptomatic intracerebral hemorrhage (sICH): Rates approximately 4.3-7.8% 3
- Angioedema
- Systemic bleeding
Time Considerations
- Earlier treatment with tPA is associated with better outcomes 1
- Treatment window:
Subsequent Management
- Transfer to dedicated stroke unit for multidisciplinary care 2
- Initiate early mobilization when hemodynamically stable 2
- Begin rehabilitation within 24-48 hours for stable patients 2
- Start secondary stroke prevention measures based on stroke etiology 2
Special Considerations for Corona Radiata Strokes
- Corona radiata strokes may have significant impact on motor function, particularly affecting finger extensors 5
- Recovery may continue over an extended period (months to years) 5
- Early rehabilitation is crucial for maximizing functional recovery 2
Remember that the time window for tPA administration is critical - "time is brain" - and every effort should be made to minimize door-to-needle time, with a goal of less than 60 minutes from hospital arrival to tPA administration.